Weiwei Liu

August 31, 2022

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker

Abstract Background: N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. YT521-B homology domain…

September 23, 2021

Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma

Abstract Metabolic pattern reconstruction is an important factor in tumor progression. Metabolism of tumor cells is characterized by abnormal increase…